We heard this week about the encouraging news of a new CRISPR-stem cell collaboration between stem cell biotech ViaCyte and CRISPR Therapeutics. The goal of the team is to make genetically engineered pancreatic derivatives from stem cells that would have […]

The post Quick Q&A with ViaCyte CEO on CRISPR-stem cell work appeared first on The Niche.